# NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB

> **NCT03604848** · NA · UNKNOWN · sponsor: **Huashan Hospital** · enrollment: 488 (estimated)

## Conditions studied

- Multidrug Resistant Tuberculosis

## Interventions

- **DRUG:** WHO-approved MDR-TB regimen
- **DRUG:** NGS-guided regimen: Regimen A
- **DRUG:** NGS-guided regimen: Regimen B
- **DRUG:** NGS-guided regimen: Regimen C

## Key facts

- **NCT ID:** NCT03604848
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-05
- **Primary completion:** 2024-08-04
- **Final completion:** 2024-08-04
- **Target enrollment:** 488 (ESTIMATED)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03604848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03604848, "NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03604848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*